Draft Australian Guidelines on ADHD
- » NHMRC statement: NHMRC consideration of RACP's draft ADHD guielines deferred pending outcome of USA investigation
- » Media release: Draft ADHD Guidelines released (30 Nov 09)
- » Background on the ADHD Guidelines
On this page
Download the draft guideline and literature review
- » LATEST DRAFT 2009 Australian Guidelines on Attention Deficit Hyperactivity Disorder (PDF, 4.6MB)

- » LATEST DRAFT Australian Guidelines on Attention Deficit Hyperactivity Disorder (ADHD)
Systematic Review (PDF, 1.7MB)

- » LATEST DRAFT Australian Guidelines on Attention Deficit Hyperactivity Disorder - Appendices (PDF, 914KB)

Additional information on the treatment of ADHD
In order to assist health practitioners and public with information on ADHD, we have established this portal containing useful information and links from a number of respected national and international bodies. This information includes the latest draft RACP Australian Guidelines on Attention Deficit Hyperactive Disorder (which are yet to be considered for approval by the Council of NHMRC).
For health care professionals
National Prescribing Service resources on use of ADHD medication
Detailed information for health practitioners on four ADHD medications approved for use in Australia, including PBS authority requirements, dosing issues, safety issues and patient information.
Royal Australian and New Zealand College of Psychiatrists Position Statement on ADHD
This three page position statement on ADHD from the Royal Australian and New Zealand College of Psychiatrists includes a definition of ADHD and recommendations for diagnosis and treatments. Information provided is equally valuable for health practitioners and consumers.
UK NHS National Institute for Health and Clinical Excellence ADHD Guideline
The UK’s National Institute for Health and Clinical Excellence ADHD guideline provides valuable information and advice for health practitioners and consumers on the care, treatment and support that children, young people and adults with ADHD should be offered and how families and carers can support people with ADHD. It does not specifically look at treatment of children younger than 3 years. Information is aimed at health practitioners and consumers.
For consumers
Consumer Medicines Information (CMI) search
This tool helps consumers find all available consumer medicines information about prescription and pharmacist-only medicines. The information is presented in a leaflet and includes a description of the product and headings such as how to take your medicines and side effects.
Medicines Talk
Medicines talk is a free quarterly newsletter written for consumers by consumers. It provides reliable and accurate information and useful hints for managing medicines.
Medicines Update
Medicines update is designed to inform consumers about new medicines and new PBS listings. Each issue provides an independent assessment of current information and research about a different medicine.
View Publications by Subjects
Help
Linked documents tagged with the PDF icon Note: Attempting to open large PDF files within the browser window may lead to system problems. For more information see Troubleshooting and access of large pdf documents. |